However, unlike AML blasts which are predominantly BCL-2 dependent [42], ALL blasts often exhibit anti-apoptotic dependence on both BCL-2 and BCL-xL [43–45]; with exception to specific subtypes [44, 46, 47]. This evidence concerns the gene BCL2L1 and acute myeloid leukemia.